Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3840

IVD Market by Product Type (Reagents, Instruments and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI 17336
Pages: 240
Sep 2017 | 13722 Views
face gplus_n
Author's : Abha Thakur
Tables: 133
Charts: 53
twit_n pr_n

IVD Market Overview:

Global IVD Market accounted for $61,103 million in 2016, and is estimated to reach at $84,647 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. In vitro diagnostic is used to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae. These IVD products can be instruments, reagents, or any system used for the diagnosis of diseases.

Increase in incidence of chronic and infectious diseases and increase in geriatric population drive the global IVD market. In addition, growth in the number of public and private diagnostic centers, and point of caring centers is expected to fuel the market during the analysis period. Furthermore, rise in investment for the advancement of healthcare sector by government is anticipated to boost the market growth. However, stringent government regulations for the manufacturing of IVD products and inadequate reimbursement policies are expected to hamper the market growth. Ongoing R&D activities related to IVD are anticipated to present new opportunities for the growth of IVD market.

IVD Market

Segment Review

Based on product type, the IVD market is categorized into reagents, instruments, and software & services. The reagent segment accounted for the highest market share in 2016, and the software and services is expected to grow at the highest growth rate during the forecast period. The growth of the reagent market is attributed to the recent introduction of new novel reagents and wide availability of effective and cost-efficient reagents. On the basis of technique, the immunodiagnostics segment captured the highest market share in 2016, owing to the increase in demand for personalized medicines. On the basis of application, infectious diseases segment captured the highest market share in 2016, owing to the increase in prevalence of infectious diseases and rise in preventive healthcare awareness among the population. Based on end users, the standalone laboratory segment captured the highest market share in 2016, primarily due to non-availability of complex tests in hospitals and commercial clinics.

Geographical Review

By geography, IVD market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest share of the market in 2016, followed by Europe. However, Asia-Pacific is anticipated to witness the highest growth rate during the forecast period. In addition, this region is expected to emerge as the area with maximum growth potential due to the focus of key players in the emerging economies and improvement in the healthcare infrastructure.

Increase in Incidence of Infectious Diseases

In the current business scenario, there is an increase in the incidence of chronic diseases such as tuberculosis (TB), cancer, cardiovascular diseases, and diabetes. In addition, there is a substantial rise in the number of patients suffering from infectious diseases, such as gastrointestinal, respiratory, and sexually transmitted diseases (STDs). The rise in these diseases increase the demand for diagnostic devices, which drives the IVD market. In 2011, approximately 5 million deaths occurred due to these diseases (AIDS, malaria & TB). The WHO estimated that 8.7 million cases of TB, of which, 1.4 million patients succumbed to this disease. Cancer caused 7.9 million deaths in 2011 and is expected to reach 11 million by 2030. In addition, diseases such as cardiovascular and diabetes increase the demand for in vitro diagnostics solutions.

Technological Advancements

In the past 50 years, IVD technologies were used only in clinical labs. Initially, pregnancy test was undertaken in laboratories; however, these days, one can take the tests at home by placing urine samples on test sticks. These tests are accurate, less time-consuming, and can be easily performed. Similarly, the blood glucose levels testing can be done using point of care testing devices such as glucometer. Similarly, the HIV test can also be conducted at home using a mouth swab that is inbuilt in the diagnosis device provides results in 20-40 minutes.

Previously, these tests were carried out in clinical laboratories, where blood sample of the individual was taken. As there are various advancements in the conventional technologies of IVD, there is increase in demand for IVD in the market. These advancements contribute in driving the global IVD market. Recently, Life Technology Corporation launched CE-IVD Marked QuantStudio Dx Real Time PCR instrument in Europe. Quant Studio Real Time PCR provides various diagnostic functions such as pathogen detection, SNP genotyping, gene expression analysis, mutation detection copy number analysis, and micro-RNA.

Major companies operating in IVD market adopted product launch as their key development strategy. Companies profiled in this market include Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

Key Benefits:

  • The study provides in-depth analysis of the global IVD market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis of the industry is provided for the period of 2016-2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by technology and application helps understand various trends and prevailing opportunities in the market.
  • Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies.
  • The key market players are profiled and their strategies are analyzed to predict the competitive outlook of the market.

IVD Market Key Segments:

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Techniques

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassays (CLIAS)
      • Fluorescence Immunoassays (FIAS)
      • Colorimetric Immunoassays (CIS)
    • Rapid Tests
    • Enzyme-Linked Immunospot Assays (ELISPOT)
    • Radioimmunoassay
    • Western Blot
  • Blood Testing
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA Diagnostics
    • Microarrays
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Renal Profile
    • Electrolyte Panel
    • Specialty Chemicals
  • Other IVD Techniques

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Other Indications

By End Users

  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Point of Care Testing
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS

3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. Threat of substitute
3.3.5. Competitive rivalry

3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increasing incidence of chronic and infectious diseases
3.5.1.2. Technological advancements in IVD
3.5.1.3. Emergence of minimal invasive technologies
3.5.1.4. Increasing government expenditures on healthcare
3.5.1.5. Increase in popularity of personalized medicine approach

3.5.2. Restraint

3.5.2.1. Unclear reimbursement policies
3.5.2.2. Stringent regulatory policies

3.5.3. Opportunity

3.5.3.1. Potential opportunities for outsourcing
3.5.3.2. Convergence of new technologies

Chapter: 4 IVD MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. REAGENTS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. INSTRUMENTS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. SOFTWARE AND SERVICES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 IVD MARKET, BY TECHNIQUE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. IMMUNODIAGNOSTICS

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1. Market size and forecast
5.2.4.2. Chemiluminescence immunoassay (CLIA)

5.2.4.2.1. Market size and forecast

5.2.4.3. Fluorescence immunoassay (FIA)

5.2.4.3.1. Market size and forecast

5.2.4.4. Colorimetric immunoassay (CI)

5.2.4.4.1. Market size and forecast

5.2.5. Rapid tests

5.2.5.1. Market size and forecast

5.2.6. Enzyme-linked Immunospot (ELISPOT)

5.2.6.1. Market size and forecast

5.2.7. Radioimmunoassay (RIA)

5.2.7.1. Market size and forecast

5.2.8. Western blot

5.2.8.1. Market size and forecast

5.3. BLOOD TESTING

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.4. MOLECULAR DIAGNOSTICS

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Polymerize chain reaction (PCR)

5.4.4.1. Market size and forecast

5.4.5. Isothermal nucleic acid technology (INAAT)

5.4.5.1. Market size and forecast

5.4.6. Hybridization

5.4.6.1. Market size and forecast

5.4.7. DNA diagnostics

5.4.7.1. Market size and forecast

5.4.8. Microarray

5.4.8.1. Market size and forecast

5.4.9. Others

5.4.9.1. Market size and forecast

5.5. TISSUE DIAGNOSTICS

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.6. CLINICAL CHEMISTRY

5.6.1. Key market trends
5.6.2. Key growth factors and opportunities
5.6.3. Market size and forecast
5.6.4. Basic metabolic panel

5.6.4.1. Market size and forecast

5.6.5. Liver panel

5.6.5.1. Market size and forecast

5.6.6. Renal profile

5.6.6.1. Market size and forecast

5.6.7. Lipid profile

5.6.7.1. Market size and forecast

5.6.8. Thyroid function panel

5.6.8.1. Market size and forecast

5.6.9. Electrolyte panel

5.6.9.1. Market size and forecast

5.6.10. Speciality chemicals

5.6.10.1. Market size and forecast

5.7. OTHER IVD TECHNIQUES

5.7.1. Key market trends
5.7.2. Key growth factors and opportunities
5.7.3. Market size and forecast

Chapter: 6 IVD MARKET, BY APPLICATION

6.1. INFECTIOUS DISEASES

6.1.1. Key market trends
6.1.2. Key growth factors and opportunities
6.1.3. Market size and forecast

6.2. CANCER

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.3. CARDIAC DISEASES

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.4. IMMUNE SYSTEM DISORDERS

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.5. NEPHROLOGICAL DISEASES

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.6. GASTROINTESTINAL DISEASES

6.6.1. Key market trends
6.6.2. Key growth factors and opportunities
6.6.3. Market size and forecast

6.7. OTHER INDICATIONS

6.7.1. Key market trends
6.7.2. Key growth factors and opportunities
6.7.3. Market size and forecast

Chapter: 7 IVD MARKET BY END USERS

7.1. STANDALONE LABORATORIES

7.1.1. Market size and forecast

7.2. HOSPITALS

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.3. ACADEMIC AND MEDICAL SCHOOLS

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.4. POINT OF CARE TESTING

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.5. OTHERS END-USER

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

Chapter: 8 IVD MARKET BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S.

8.2.4.1. Market size and forecast

8.2.5. Canada

8.2.5.1. Market size and forecast

8.2.6. Mexico

8.2.6.1. Market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. Germany

8.3.4.1. Market size and forecast

8.3.5. France

8.3.5.1. Market size and forecast

8.3.6. UK

8.3.6.1. Market size and forecast

8.3.7. Spain

8.3.7.1. Market size and forecast

8.3.8. Italy

8.3.8.1. Market size and forecast

8.3.9. Rest of Europe

8.3.9.1. Market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. India

8.4.4.1. Market size and forecast

8.4.5. China

8.4.5.1. Market size and forecast

8.4.6. Japan

8.4.6.1. Market size and forecast

8.4.7. Australia

8.4.7.1. Market size and forecast

8.4.8. South Korea

8.4.8.1. Market size and forecast

8.4.9. Rest of Asia-Pacific

8.4.9.1. Market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Latin America

8.5.4.1. Market size and forecast

8.5.5. Middle East

8.5.5.1. Market size and forecast

8.5.6. Africa

8.5.6.1. Market size and forecast

Chapter: 9 COMPANY PROFILES

9.1. ALERE INC.

9.1.1. Company overview
9.1.2. Business performance
9.1.3. Key strategies and developments

9.2. BAYER AG

9.2.1. Company overview
9.2.2. Business performance
9.2.3. Key strategies and development

9.3. BECTON DICKINSON AND COMPANY

9.3.1. Company overview
9.3.2. Business performance
9.3.3. Key strategies and development

9.4. BIOMERIEUX

9.4.1. Company overview
9.4.2. Business performance
9.4.3. Key strategies and developments

9.5. BIO-RAD LABORATORIES

9.5.1. Company overview
9.5.2. Business performance
9.5.3. Key strategies and developments

9.6. DANAHER CORPORATION

9.6.1. Company overview
9.6.2. Business performance
9.6.3. Key strategies and development

9.7. F. HOFFMANN-LA ROCHE AG

9.7.1. Company overview
9.7.2. Business performance
9.7.3. Key strategies and developments

9.8. JOHNSON & JOHNSON

9.8.1. Company overview
9.8.2. Business performance
9.8.3. Key strategies and developments

9.9. SYSMEX CORPORATION

9.9.1. Company overview
9.9.2. Business performance
9.9.3. Key strategies and developments

9.10. THERMO FISHER SCIENTIFIC INC.

9.10.1. Company overview
9.10.2. Business performance
9.10.3. Key strategies and development

List of Tables

TABLE 1. GLOBAL INCIDENCE OF DISEASES
TABLE 2. GLOBAL IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3. IVD MARKET FOR REAGENTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. IVD MARKET FOR INSTRUMENTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. IVD MARKET FOR SOFTWARE & SERVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7. GLOBAL IVD MARKET FOR IMMUNODIAGNOSTICS, BY TYPES, 2016-2023 ($MILLION)
TABLE 8. IVD MARKET FOR IMMUNODIAGNOSTICS, BY GEOGRAPHY,2016-2023 ($MILLION)
TABLE 9. GLOBAL IMMUNODIAGNOSTIC MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10. IVD MARKET FOR BLOOD TESTING, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL IVD MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2016-2023 ($MILLION)
TABLE 12. IVD MARKET FOR MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. IVD MARKET FOR TISSUE DIAGNOSTICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. GLOBAL IVD MARKET FOR CLINICAL CHEMISTRY, BY TYPE, 2016-2023 ($MILLION)
TABLE 15. IVD MARKET FOR CLINICAL CHEMISTRY, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. OTHER IVD TECHNIQUES MARKET, BY GEOGRAPHY, 2016-2023, ($MILLION)
TABLE 17. GLOBAL IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 18. IVD MARKET FOR INFECTIOUS DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. IVD MARKET FOR CANCER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. IVD MARKET FOR CARDIAC DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. IVD MARKET FOR IMMUNE SYSTEM DISORDER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. IVD MARKET FOR NEPHROLOGICAL DISEASES, BY GEOGRAPHY, 2016-2023, ($MILLION)
TABLE 23. IVD MARKET FOR GASTROINTESTINAL DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. IVD MARKET FOR OTHER INDICATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. GLOBAL IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 26. IVD MARKET FOR STANDALONE LABORATORIES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27. IVD MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. IVD MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29. IVD MARKET FOR POINT OF CARE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. IVD MARKET FOR OTHER END-USER, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. IVD MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 37. U.S. IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. U.S. IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 39. U.S. IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. U.S. IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 41. CANADA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 42. CANADA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 43. CANADA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. CANADA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 45. MEXICO IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 46. MEXICO IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 47. MEXICO IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 48. MEXICO IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 49. EUROPE IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 50. EUROPE IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 51. EUROPE IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 52. EUROPE IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 53. EUROPE IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 54. GERMANY IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 55. GERMANY IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 56. GERMANY IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 57. GERMANY IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 58. FRANCE IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 59. FRANCE IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 60. FRANCE IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 61. FRANCE IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 62. UK IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 63. UK IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 64. UK IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 65. UK IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 66. SPAIN IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 67. SPAIN IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 68. SPAIN IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 69. SPAIN IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 70. ITALY IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 71. ITALY IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 72. ITALY IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 73. ITALY IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 74. REST OF EUROPE IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 75. REST OF EUROPE IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 76. REST OF EUROPE IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 77. REST OF EUROPE IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 78. ASIA-PACIFIC IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 79. ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 80. ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 81. ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 82. ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 83. INDIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 84. INDIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 85. INDIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 86. INDIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 87. CHINA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 88. CHINA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 89. CHINA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 90. CHINA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 91. JAPAN IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 92. JAPAN IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 93. JAPAN IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 94. JAPAN IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 95. CATEGORIZATION OF IVD DEVICES
TABLE 96. AUSTRALIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 97. AUSTRALIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 98. AUSTRALIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 99. AUSTRALIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 100. SOUTH KOREA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 101. SOUTH KOREA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 102. SOUTH KOREA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 103. SOUTH KOREA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 105. REST OF ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 106. REST OF ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 107. REST OF ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 108. LAMEA IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 109. LAMEA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 110. LAMEA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 111. LAMEA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 112. LAMEA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 113. LATIN AMERICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 114. LATIN AMERICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 115. LATIN AMERICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 116. LATIN AMERICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 117. MIDDLE EAST IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 118. MIDDLE EAST IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 119. MIDDLE EAST IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 120. MIDDLE EAST IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 121. AFRICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 122. AFRICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 123. AFRICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 124. AFRICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 125. ALERE INC. COMPANY SNAPSHOT
TABLE 126. BAYER AG COMPANY SNAPSHOT
TABLE 127. BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 128. BIOMERIEUX COMPANY SNAPSHOT
TABLE 129. BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 130. DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 131. ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 132. JOHNSON & JOHNSON. COMPANY SNAPSHOT
TABLE 133. SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 134. THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT

List of Figures

FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5. PORTER’S FIVE FORCES ANALYSIS
FIGURE 6. MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7. GLOBAL ELISA MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY (CLISA), 2016-2023 ($MILLION)
FIGURE 8. GLOBAL ELISA MARKET FOR FLUORESCENCE IMMUNOASSAY (FIA), 2016-2023 ($MILLION)
FIGURE 9. GLOBAL ELISA MARKET FOR COLORIMETRIC IMMUNOASSAY (CI), 2016-2023 ($MILLION)
FIGURE 10. GLOBAL IMMUNODIAGNOSTICS MARKET FOR RAPID TESTS, 2016-2023 ($MILLION)
FIGURE 11. GLOBAL IMMUNODIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSPOT (ELISPOT), 2016-2023 ($MILLION)
FIGURE 12. GLOBAL IMMUNODIAGNOSTICS MARKET FOR RADIOIMMUNOASSAY (RIA), 2016-2023 ($MILLION)
FIGURE 13. GLOBAL IMMUNODIAGNOSTICS MARKET FOR WESTERN BLOT, 2016-2023 ($MILLION)
FIGURE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, 2016-2023 ($MILLION)
FIGURE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT), 2016-2023 ($MILLION)
FIGURE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, 2016-2023($MILLION)
FIGURE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA DIAGNOSTICS, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNIQUE, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL CLINICAL CHEMISTRY MARKET FOR BASIC METABOLIC PANEL, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL CLINICAL CHEMISTRY MARKET FOR LIVER PANEL, 2016-2023 ($MILLION)
FIGURE 22. GLOBAL CLINICAL CHEMISTRY MARKET FOR RENAL PROFILE, 2016-2023 ($MILLION)
FIGURE 23. GLOBAL CLINICAL CHEMISTRY MARKET FOR LIPID PROFILE, 2016-2023 ($MILLION)
FIGURE 24. GLOBAL FOR MARKET THYROID FUNCTION PANEL, 2016-2023 ($MILLION)
FIGURE 25. GLOBAL CLINICAL CHEMISTRY MARKET FOR ELECTROLYTE PANEL, 2016-2023 ($MILLION)
FIGURE 26. GLOBAL CLINICAL CHEMISTRY MARKET FOR SPECIALITY CHEMICALS, 2016-2023 ($MILLION)
FIGURE 27. ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28. ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29. ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30. BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 31. BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32. BAYER AG: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33. BECTON DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 34. BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 35. BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36. BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 37. BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 38. BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 39. BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 40. DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 41. DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 42. DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 43. ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 44. ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 45. ROCHE DIAGNOSTICS: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 46. JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 47. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 48. JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 49. SYSMEX CORPORATION: REVENUE, 2015-2017 ($MILLION)
FIGURE 50. SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51. THERMO FISHER SCIENTIFIC INC. REVENUE, 2014-2016, ($MILLION)
FIGURE 52. THERMO FISHER SCIENTIFIC INC. REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 53. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

 

In vitro diagnostics are used to analyze the samples such as blood, urine, and tissue to diagnose a medical condition or any disease. The growth within this market can be attributed to increased awareness toward healthcare, the increase in number of people willing to undergo preventive health check-ups, availability of disease-specific test instruments, and corporate setups promoting awareness of health among employees. The IVD instrument manufacturing companies have now decided to expand their markets in tier-2 and tier-3 cities, which is expected to give them a chance to tap market segments having high revenue generation capacity.

North America held the highest market share owing to increase in baby boomer population, rise in demand for minimally invasive surgical procedures, and substantial expenditure on healthcare by government reforms. Asia-Pacific possesses the highest market potential due to surge in demand for better healthcare services, significant investments by government to improve healthcare infrastructure, and growth of medical tourism industry in emerging countries. Rise of medical tourism in emerging economies in Asia-Pacific, such as China, India, Brazil, Mexico, Malaysia, Thailand, Singapore, and South Korea, offers high growth opportunities for minimally invasive surgical instrument manufacturers. According to the report of Economic Co-operation and Development (OECD), healthcare is costlier in developed countries. However, India is popular because of its high-quality care provided at lower costs.

Major companies involved in the global IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts